XSHE
300018
Market cap947mUSD
Jul 10, Last price
13.51CNY
1D
2.74%
1Q
2.12%
Jan 2017
14.69%
IPO
58.75%
Name
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Wuhan, China, Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. operates extensively across the smart grid and healthcare industries within the nation. Its core capabilities in the smart grid arena encompass the full lifecycle of product development, from research and design to manufacturing, sales, and ongoing support. This includes sophisticated systems for intelligent recording and analytical processing of power data, precise time synchronization, holistic substation automation, and advanced distribution network automation. The firm's diverse product range features power fault recording apparatus, time synchronization units, integrated substation automation equipment, intelligent distribution network devices, and a variety of smart grid diagnostic tools. Additionally, the company is active in the healthcare sphere, providing medical informatization solutions and specialized in-vitro diagnostic products. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. was founded in 2001.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||